| Added by | pcoopman |
|---|---|
| Group name | EquipePC |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://bmjopen.bmj.com/content/bmjopen/12/3/e055821.full.pdf |
| Accessed | 2023/11/20 - 19:12:50 |
| Date Added | 2023/11/20 - 18:12:50 |
| Date Modified | 2023/11/20 - 18:12:50 |
| Parent item | Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1 |
Institut de Recherche en Cancérologie de
